Latest SpectraCure News & Updates

See the latest news and media coverage for SpectraCure. We track all announcements, press releases, and industry mentions in real time, all in one place.

SpectraCure

Developer of photodynamic treatment systems for prostate cancer

spectracure.com

Headquarters: Sweden
Founded year: 2003
Company type: Public company
Number of employees: 23–50
Industry: Advanced Medical Equipment & Technology

Last updated August 21

Latest news about SpectraCure

In short: SpectraCure reported positive 12-month prostate cancer data and completed a 34.2 MSEK rights issue.

Company announcements

August 21 SpectraCure

SpectraCure publishes half-year report for the second quarter of 2026

The company reports a result after tax of -12.9 MSEK and carried out a rights issue. Clinical studies for prostate cancer are progressing with planned phase 2 completion.

August 4 SpectraCure

SpectraCure announces preliminary outcome: approximately 50.6 percent subscribed

Guarantee commitments of 24.4 percent are utilized and the company is provided with approximately SEK 25.7 million before costs. Final outcome is expected on August 6, 2026.

July 21 SpectraCure

SpectraCure carries out a rights issue of approximately 34.2 MSEK

The proceeds will finance the completion of phase 2, the primary study, as well as preparations for phase 3.

July 15 SpectraCure

SpectraCure held an extraordinary general meeting on July 15, 2026

The meeting decided on changes to the articles of association, capital reduction, and rights issue.

Media coverage

August 21 Zone Bourse

SpectraCure AB (publ) publishes its results for the second quarter and the first half-year ended June 30, 2026

SpectraCure AB has published its financial results for the second quarter and the first half-year ended June 30, 2026. For the second quarter, the...

August 7 AffärsVärlden

SpectraCure: 75% subscribed – three new flags

SpectraCure's rights issue of units was subscribed to 75% including guarantee commitments. Emissionsguiden raises three retroactive flags.

July 29 AffärsVärlden

New flag in SpectraCure's rights issue

The medical technology company SpectraCure has released the memorandum for its rights issue of SEK 34 million and Emissionsguiden raises a new flag for insufficient information.

June 24 AffärsVärlden

SpectraCure: New issue at 3 öre after price slaughter

SpectraCure has decided on a rights issue that could provide the company with 34 million SEK before costs.

Never miss news about SpectraCure

Track SpectraCure and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

SpectraCure competitors & trending companies

Browse news for competitors to SpectraCure and other trending companies.